Clinical and Biological Predictors of COVID-19 Disease in Older Patients
NCT ID: NCT04348396
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2020-04-03
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In particular, socioeconomic, diagnostic, biological, functional, therapy data will be collected at the patients' admission, during hospital stay, at the discharge and 1, 3, 6, 12 months after discharge.
Results and findings will help support changes in clinical practice and decision making, with the aim to reduce the use of healthcare services and the healthcare expenditure.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes in Hospitalized Older Patients With COVID-19
NCT04385212
Risk Factors for COVID-19 Mortality
NCT04786808
Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults
NCT04362943
Prognostic Score in Covid-19
NCT04780373
Model to Predict Coinfection in Elderly Patients With COVID-19
NCT06321367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the ReportAge-COVID project aims to collect - using a minimum clinical and biological data set - a series of data and indicators on the conditions of elderly patients that are suspected of having a compatible clinical picture or were confirmed positive for COVID-19. Data will be collected at the patients' admission, during hospital stay, at discharge and 1, 3, 6, 12 months after discharge.
In particular, the following specific pieces of information will be gathered:
* routinely collected demographic, socioeconomic, clinical, biological and diagnostic data
* frailty condition (by using the clinical frailty scale)
* assessment of the functional capacities through ADL and IADL tests
* health conditions; nutritional status; medications; treatments and procedures
* biomarkers of aging including cytokines and anti-inflammatory molecules, previously identified in a focus group of experts
Results and findings will help support changes in clinical practice and decision making, with the aim of reducing adverse outcomes, the worsening of health conditions in the elderly population, the use of healthcare services and, as a consequence, lower healthcare expenditure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly patients affected by COVID-19
The group taken into consideration consists of elderly patients hospitalized with diagnosed COVID-19.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Nazionale di Ricovero e Cura per Anziani
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS INRCA Hospital
Ancona, , Italy
IRCCS INRCA Hospital
Casatenovo, , Italy
IRCCS INRCA Hospital
Fermo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
IRCCS INRCA website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INRCA_01_2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.